We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| DXS International Plc | AQSE:DXSP | Aquis Stock Exchange | Ordinary Share | GB00B2Q6HZ92 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.35 | 1.00 | 2.20 | 1.60 | 1.35 | 1.35 | 0.00 | 15:29:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2021 to May 2024
TIDMDXSP
DXS INTERNATIONAL PLC
Award AQSE Company of the Year
("DXSP")
DXS International ("DXSP" or "the Company"), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is delighted to announce that at the ninth Annual Small Cap Awards held yesterday evening at London's Montcalm Hotel the Company won the award for "AQSE Company of the Year".
The Small Cap Awards shine a light on the best companies and participants in the small and micro-cap community (sub GBP200m market capitalisation) across nine categories. They are a once-in-a-year opportunity to recognise outstanding achievement focused on smaller quoted companies.
Commenting on DXS's Awards success, David Immelman, CEO of DXS said:
"These awards are deserved recognition for the Company's outstanding performance over the past year which has seen the business maintain and grow its revenue and profits. I am delighted to see the hard work of all our staff in challenging circumstances recognised by the judging panel. The Covid-19 pandemic has added new impetus to the realization that health care delivery is urgently in need of a major overhaul and DXS, with deep knowledge and experience in the electronic health care space, is well-positioned to exploit this fast-emerging opportunity. "
The Directors of DXS International plc accept responsibility for this announcement.
Contacts:
David Immelman (Chief Executive) 01252 719800 DXS International plc david@dxs-systems.com https://www.dxs-systems.co.uk Corporate Advisor City & Merchant David Papworth 020 7101 7676 Corporate Broker Hybridan LLP Claire Louise Noyce 020 3764 2341
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.
(END) Dow Jones Newswires
November 12, 2021 08:00 ET (13:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year DXS Chart |
1 Month DXS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
